Skip to main content
Journal cover image

Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Publication ,  Journal Article
Kim, S-N; Doo, A-R; Park, J-Y; Choo, HJ; Shim, I; Park, JJ; Chae, Y; Lee, B; Lee, H; Park, H-J
Published in: Brain research
January 2014

This study first showed the behavioural benefits of novel combination therapy of L-dopa with acupuncture on Parkinson's disease, and its underlying mechanisms within basal ganglia. The previous study reported that acupuncture may improve the motor function of a Parkinson's disease (PD) mouse model by increasing the dopamine efflux and turnover ratio of dopamine. Hence, we hypothesised that combining L-dopa with acupuncture would have a behavioural benefit for those with PD. We performed unilateral injections of 6-OHDA into the striatum of C57Bl/6 mice to model hemi-Parkinsonian attributes. To test motor function and dyskinetic anomalies, we examined cylinder behaviour and abnormal involuntary movement (AIM), respectively. We found that (1) a 50% reduced dose of L-dopa (7.5 mg/kg) combined with acupuncture showed an improvement in motor function that was comparable to mice given the standard dose of L-dopa treatment (15 mg/kg) only, and that (2) the combination treatment (L-dopa +acupuncture) was significantly superior in reducing AIM scores when equivalent doses of L-dopa were used. The combination treatment also significantly reduces the abnormal increase of GABA contents in the substantia nigra compared to the standard L-dopa treatment. Furthermore, abnormal expression of FosB, the immediate early gene of L-dopa induced dyskinesia (LID), was mitigated in the striatum by the combination treatment. All of these results indicate that acupuncture enhances the benefits of L-dopa on motor function with reduced dose of L-dopa and alleviating LID by normalising neurochemical imbalance within the basal ganglia.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Brain research

DOI

EISSN

1872-6240

ISSN

0006-8993

Publication Date

January 2014

Volume

1544

Start / End Page

33 / 44

Related Subject Headings

  • gamma-Aminobutyric Acid
  • Substantia Nigra
  • Proto-Oncogene Proteins c-fos
  • Parkinson Disease, Secondary
  • Oxidopamine
  • Neurology & Neurosurgery
  • Movement
  • Mice, Inbred C57BL
  • Mice
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, S.-N., Doo, A.-R., Park, J.-Y., Choo, H. J., Shim, I., Park, J. J., … Park, H.-J. (2014). Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance. Brain Research, 1544, 33–44. https://doi.org/10.1016/j.brainres.2013.11.028
Kim, Seung-Nam, Ah-Reum Doo, Ji-Yeun Park, Hyunwoo J. Choo, Insop Shim, Jongbae J. Park, Younbyoung Chae, Bena Lee, Hyejung Lee, and Hi-Joon Park. “Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.Brain Research 1544 (January 2014): 33–44. https://doi.org/10.1016/j.brainres.2013.11.028.
Kim, Seung-Nam, et al. “Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.Brain Research, vol. 1544, Jan. 2014, pp. 33–44. Epmc, doi:10.1016/j.brainres.2013.11.028.
Kim S-N, Doo A-R, Park J-Y, Choo HJ, Shim I, Park JJ, Chae Y, Lee B, Lee H, Park H-J. Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance. Brain research. 2014 Jan;1544:33–44.
Journal cover image

Published In

Brain research

DOI

EISSN

1872-6240

ISSN

0006-8993

Publication Date

January 2014

Volume

1544

Start / End Page

33 / 44

Related Subject Headings

  • gamma-Aminobutyric Acid
  • Substantia Nigra
  • Proto-Oncogene Proteins c-fos
  • Parkinson Disease, Secondary
  • Oxidopamine
  • Neurology & Neurosurgery
  • Movement
  • Mice, Inbred C57BL
  • Mice
  • Male